Since the upregulation of NUPR1 correlates with poor clinical outcomes in ER+ and ERBB2 (HER2)-enriched breast cancer patients, we sought to further confirm the role of NUPR1 in the induction of estrogen independence in ER+ breast cancer cells. Here, NUPR1 is linked to breast cancer.